GlassScriptPhysician profile
Mamie S Bowers
NPI 1124014402
$3,083.92
in general payments reported to CMS, 2019-2025
24 companies · $325 in 2025
The $325 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,458 · 2020: $235 · 2021: $106 · 2022: $243 · 2023: $402 · 2024: $315 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $646 · Education: $396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $646.10 |
| Education | $396.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celularity INC. | $915.00 | 2019 | |
| Astellas Pharma US INC | $617.93 | 2019-2025 | Veozah |
| Abbvie INC. | $408.05 | 2019-2025 | Liletta |
| Daiichi Sankyo INC. | $188.79 | 2019-2024 | Injectafer |
| Allergan, INC. | $156.56 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $95.17 | 2023-2025 | Myfembree |
| Exact Sciences Corporation | $92.74 | 2023-2025 | Cologuard Collection Kit |
| Millicent US INC | $80.57 | 2019-2025 | Femlyv, Femring, Intrarosa |
| Boston Scientific Corporation | $71.77 | 2019-2022 | |
| Hologic Sales and Service, LLC | $59.63 | 2019 | |
| Exeltis, USA INC. | $56.05 | 2019-2023 | Slynd |
| Avion Pharmaceuticals | $54.38 | 2019-2020 | |
| Therapeuticsmd, INC. | $52.63 | 2019 | |
| Medtronic, INC. | $51.60 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.50 | 2020-2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $28.07 | 2025 | Evenity, Prolia |
| Lupin INC. | $27.50 | 2019 | |
| Dysis Medical, INC. | $24.98 | 2022 | |
| Agile Therapeutics, INC. | $16.49 | 2023 | Twirla |
| Evofem Biosciences, INC. | $14.57 | 2024 | |
| Minerva Surgical, INC | $12.78 | 2019 | |
| Amag Pharmaceuticals, INC. | $11.25 | 2019 | |
| Alydia Health | $5.91 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mamie Bowers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.